Inclusion Criteria:  Healthy children aged 1 to 12 years (inclusive) at the time of inclusion. Willingness of parent or legal guardian to provide written informed consent prior to screening procedures. Willingness of the relatives of the participant to provide written informed consent if they are ≥ 18 years (or an assent when they are 13 to 17 years old). Available, able, and willing to participate in all study visits and procedures  Exclusion Criteria:  History of severe local or systemic reactions to any vaccination or a history of severe allergic reactions, or known allergy to the components of the vaccines. Ongoing participation in another clinical trial Participation in previous Ebola vaccine trials Receipt of a licensed vaccine within 14 days of planned study immunization (30 days for live vaccines) Presence of any febrile illness (fever >38°C) or any moderate to severe illness within one week prior to vaccination; Administration of immunoglobulins and/or any blood products within the 120 days preceding study entry or planned administration during the study period Any other significant finding that in the opinion of the investigator would increase the risk of the individual having an adverse outcome from participating in this study.